5 therapeutic pharmaceuticals for medical use for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; dietetic foods adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; medical diagnostic reagents and assays for testing body fluids for microorganisms for modifying the microbial composition or metabolic output of the human microbiome